Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and BoneIlka Isfort, Marcel Trautmann|Scientific Reports|2019Cited by 37
Abstract 1028: A tumor-agnostic YAP/TAZ score predicts TEAD inhibitor sensitivity independent of Hippo alterationsMichael Wegert-Verhoeven, Sebastian M. Dieter, Małgorzata Oleś et al.|Cancer Research|2026Cited by 0